{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:19:50Z","timestamp":1791181190604,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T00:00:00Z","timestamp":1170892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9,14]]},"DOI":"10.1007\/s10067-007-0558-5","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T08:16:23Z","timestamp":1170836183000},"page":"1627-1633","source":"Crossref","is-referenced-by-count":35,"title":["Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis"],"prefix":"10.1007","volume":"26","author":[{"given":"Eriko","family":"Kudo-Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Mima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Katada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Ikeue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Umeshita-Sasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,8]]},"reference":[{"key":"558_CR1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.1780270805","volume":"27","author":"T Pincus","year":"1984","unstructured":"Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984) Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864\u2013872","journal-title":"Arthritis Rheum"},{"key":"558_CR2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","volume":"1","author":"DL Scott","year":"1987","unstructured":"Scott DL, Symmons DP, Coulton BL, Popert AJ (1987) Long-term outcome of treating rheumatoid arthritis: results after 20\u00a0years. Lancet 1:1108\u20131111","journal-title":"Lancet"},{"key":"558_CR3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8","volume":"44","author":"M Bukhahari","year":"2001","unstructured":"Bukhahari M, Harrison B, Lunt M, Scott DGI, Symmons DPM, Silman AJ (2001) Time to first occurrence of erosions in inflammatory polyarthritis: results from prospective community-based study. Arthritis Rheum 44:1248\u20131253","journal-title":"Arthritis Rheum"},{"key":"558_CR4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/rheumatology\/40.11.1211","volume":"40","author":"MA Quinn","year":"2001","unstructured":"Quinn MA, Conaghan PG, Emery P (2001) The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology (Oxford) 40:1211\u20131220","journal-title":"Rheumatology (Oxford)"},{"key":"558_CR5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.10135","volume":"46","author":"T Mottonen","year":"2002","unstructured":"Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J et al (2002) Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 46:894\u2013898","journal-title":"Arthritis Rheum"},{"key":"558_CR6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/art.10092","volume":"46","author":"JR O\u2019Dell","year":"2002","unstructured":"O\u2019Dell JR (2002) Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 46:283\u2013285","journal-title":"Arthritis Rheum"},{"key":"558_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.10732","volume":"48","author":"RB Landewe","year":"2003","unstructured":"Landewe RB (2003) The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Arthritis Rheum 48:1\u20135","journal-title":"Arthritis Rheum"},{"key":"558_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.10083","volume":"46","author":"RB Landewe","year":"2002","unstructured":"Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM et al (2002) COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 46:347\u2013356","journal-title":"Arthritis Rheum"},{"key":"558_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"558_CR10","first-page":"383","volume":"60","author":"WJ Venrooij van","year":"2002","unstructured":"van Venrooij WJ, Hazes JM, Visser H (2002) Anticitrullinated protein\/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60:383\u2013388","journal-title":"Neth J Med"},{"key":"558_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00325481.1993.11945749","volume":"94","author":"JR Lisse","year":"1993","unstructured":"Lisse JR (1993) Does rheumatoid factor always mean arthritis? Postgrad Med 94:133\u2013134, 139","journal-title":"Postgrad Med"},{"key":"558_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"558_CR13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/art.1780341113","volume":"34","author":"A Young","year":"1991","unstructured":"Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, Isenberg D (1991) Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 34:1425\u20131429","journal-title":"Arthritis Rheum"},{"key":"558_CR14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7","volume":"43","author":"H Yamanaka","year":"2000","unstructured":"Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, Kamatani N (2000) Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 43:852\u2013858","journal-title":"Arthritis Rheum"},{"key":"558_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a predication model for persistent (erosive) arthritis. Arthritis Rheum 46:357\u2013365","journal-title":"Arthritis Rheum"},{"key":"558_CR16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the Classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"558_CR17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al (1993) Preliminary Criteria for the classification of Sjogren\u2019s syndrome. Arthritis Rheum 36:340\u2013347","journal-title":"Arthritis Rheum"},{"key":"558_CR18","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwazaki H et al (1992) Preliminary criteria for classification of Adult Onset Still\u2019s Disease. J Rheumatol 19:424\u20134730","journal-title":"J Rheumatol"},{"key":"558_CR19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 33:1065\u20131144","journal-title":"Arthritis Rheum"},{"key":"558_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HA Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AStJ, Mowat AG, Wood PHN (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"558_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"13","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. New Engl J Med 13:344\u2013346","journal-title":"New Engl J Med"},{"key":"558_CR22","first-page":"85","volume":"55","author":"B Amor","year":"1990","unstructured":"Amor B, Dougados M, Mijiyama M (1990) Criteres de classification des spondylarthropathies. Rev Rheum 55:85\u201389","journal-title":"Rev Rheum"},{"key":"558_CR23","first-page":"197","volume":"4","author":"G Pasero","year":"1986","unstructured":"Pasero G, Barbieri P (1986) Palindromic rheumatism: you just have to think about it! Clin Exp Rheumatol 4:197\u2013199","journal-title":"Clin Exp Rheumatol"},{"key":"558_CR24","first-page":"2074","volume":"29","author":"AL Jansen","year":"2002","unstructured":"Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29:2074\u20132076","journal-title":"J Rheumatol"},{"key":"558_CR25","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741\u20132749","journal-title":"Arthritis Rheum"},{"issue":"4","key":"558_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","volume":"34","author":"A Suzuki","year":"2003","unstructured":"Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M et al (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34(4):395\u2013402","journal-title":"Nat Genet"},{"issue":"Suppl","key":"558_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2005.09.004","volume":"25","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K, Yamada R (2005) Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis. J Autoimmun 25(Suppl):12\u201315","journal-title":"J Autoimmun"},{"key":"558_CR28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ard.2005.044743","volume":"65","author":"Y Takizawa","year":"2006","unstructured":"Takizawa Y, Suzuki A, Sawada T, Ohsaka M, Inoue T, Yamada R et al (2006) Citrullinated fibrinogen detected as a soluble citrullinated autoanigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 65:1013\u20131020","journal-title":"Ann Rheum Dis"},{"key":"558_CR29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","volume":"63","author":"K Forslind","year":"2004","unstructured":"Forslind K, Ahlmen M, Eberhardt K, Hafstr\u00f6m I, Svensson E (2004) Prediction of radiological outcome in early RA in clinical practice: role of antibodies to citrullinated peptide (anti-CCP). Ann Rheum Dis 63:1090\u20131095","journal-title":"Ann Rheum Dis"},{"key":"558_CR30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroots A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during three years in early rheumatoid arthritis (the TIRA project). Ann Rheum Dis 63:1085\u20131089","journal-title":"Ann Rheum Dis"},{"key":"558_CR31","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","volume":"50","author":"FA Gaalen van","year":"2004","unstructured":"van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E et al (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis. Arthritis Rheum 50:2113\u20132121","journal-title":"Arthritis Rheum"},{"key":"558_CR32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2004","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T (2004) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196\u2013201","journal-title":"Ann Rheum Dis"},{"key":"558_CR33","first-page":"689","volume":"17","author":"CH Jaarsveld van","year":"1999","unstructured":"van Jaarsveld CH, ter Borg EJ, Jacobs JW, Schellekens GA, Gmelig-Meyling FH, van Booma-Frankfort C et al (1999) The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 17:689\u2013697","journal-title":"Clin Exp Rheumatol"},{"key":"558_CR34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hooge, van\u2019t Hof MA et al (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831\u20131835","journal-title":"Arthritis Rheum"},{"key":"558_CR35","first-page":"1691","volume":"30","author":"LM Jansen","year":"2003","unstructured":"Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, de Koning MHM, Dijkmans BA (2003) The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 30:1691\u20131695","journal-title":"J Rheumatol"},{"key":"558_CR36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","volume":"62","author":"O Meyer","year":"2003","unstructured":"Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A et al (2003) Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120\u2013126","journal-title":"Ann Rheum Dis"},{"key":"558_CR37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","volume":"62","author":"J Vencovsky","year":"2003","unstructured":"Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterrova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427\u2013430","journal-title":"Ann Rheum Dis"},{"key":"558_CR38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S Bas","year":"2003","unstructured":"Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 42:677\u2013680","journal-title":"Rheumatology (Oxford)"},{"key":"558_CR39","first-page":"2535","volume":"30","author":"A Saraux","year":"2003","unstructured":"Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chales G, Le Henaff C et al (2003) Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 30:2535\u20132539","journal-title":"J Rheumatol"},{"key":"558_CR40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0558-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0558-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0558-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:05Z","timestamp":1559105465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0558-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,8]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,14]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0558-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,8]]}}}